Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability

Abstract

The majority of human cancers are genomically unstable, often with gains or losses of whole chromosomes. In high-risk human papillomavirus (HPV)-associated cervical neoplasia, the two HPV-encoded oncoproteins E6 and E7 have been implicated in mitotic infidelity by their ability to induce centrosome-related mitotic disturbances. However, the mechanisms by which HPV E6 and E7 subvert centrosome homeostasis are strikingly different. Whereas the E7 oncoprotein rapidly drives centrosome duplication errors in cells that appear phenotypically normal, expression of the HPV E6 oncoprotein results in an accumulation of supernumerary centrosomes in multinucleated cells. The primary centrosome duplication defect in HPV E7 expressing cells may be linked to the ability of E7 to disrupt regulatory nodes that govern both the host cell division cycle machinery and the initiation of centrosome duplication. Most importantly, the E7 oncoprotein has been shown to dysregulate cdk2 activity, a major determinant for the initiation of centrosome duplication. HPV-induced centrosome abnormalities, multipolar mitoses, and aneuploidy often occur at early stages during cervical carcinogenesis and increase with malignant conversion. These findings suggest that HPV oncoprotein-induced chromosomal instability increases the risk for genetic changes that may ultimately facilitate carcinogenic progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Baksch C, Wagenbach N, Nonn M, Leistritz S, Stanbridge E, Schneider A, Dürst M . 2001 Genes Chrom. Cancer 31: 196–198

  • Bardelli A, Cahill DP, Lederer G, Speicher MR, Kinzler KW, Vogelstein B, Lengauer C . 2001 Proc. Natl. Acad. Sci. USA 98: 5770–5775

  • Berezutskaya E, Bagchi S . 1997 J. Biol. Chem. 272: 30135–30140

  • Bibbo M, Dytch HE, Alenghat E, Bartels PH, Wied GL . 1989 Am. J. Clin. Pathol. 92: 261–265

  • Boveri T . 1914 Zur Frage der Entstehung maligner Tumoren G Fischer: Jena

    Google Scholar 

  • Boyer SN, Wazer DE, Band V . 1996 Cancer Res. 56: 4620–4624

  • Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T . 1999 EMBO J. 18: 2449–2458

  • Bulten J, Poddighe PJ, Robben JCM, Gemmink JH, de Wilde PCM, Hanselaar AGJM . 1998 Am. J. Pathol. 152: 495–503

  • Cahill DP, Kinzler KW, Vogelstein B, Lengauer C . 1999 Trends Cell. Biol. 9: M57–M60

  • Crum CP, Ikenberg H, Richart RM, Gissman L . 1984 N. Engl. J. Med. 310: 880–883

  • Dollard SC, Wilson JL, Demeter LM, Bonnez W, Reichman RC, Broker TR, Chow LT . 1992 Genes Dev. 6: 1131–1142

  • Duensing S, Duensing A, Crum CP, Munger K . 2001a Cancer Res. 61: 2356–2360

  • Duensing S, Duensing A, Flores ER, Do A, Lambert PF, Munger K . 2001b J. Virol. 75: 7712–7716

  • Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K . 2000 Proc. Natl. Acad. Sci. USA 97: 10002–10007

  • Duensing S, Munger K . 2001 Biochim. Biophys. Acta 2: M81–M88

  • Dyson N, Howley PM, Munger K, Harlow E . 1989 Science 243: 934–937

  • Fisk HA, Winey M . 2001 Cell 106: 95–104

  • Flores ER, Allen-Hoffmann BL, Lee D, Sattler CA, Lambert PF . 1999 Virology 262: 344–354

  • Fu YS, Reagan JW, Richart RM . 1981 Gynecol. Oncol. 12: S220–S231

  • Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA . 1997 Genes Dev. 11: 2090–2100

  • Gisselsson D . 2001 Atlas Genet. Cytogenet. Oncol. Hematol. URL://www.infobiogen.fr/services/chromcancer/Deep/ChromosomInstabilID20023.html

  • Hashida T, Yasumoto S . 1991 J. Gen. Virol. 72: 1569–1577

  • Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT . 1989 EMBO J. 8: 3905–3910

  • Hinchcliffe EH, Li C, Thompson EA, Maller JL, Sluder G . 1999 Science 283: 851–854

  • Hittelman WN . 2001 Ann. N.Y. Acad. Sci. 952: 1–12

  • Howley PM, Lowy DR . 2001 Field's Virology Vol. 2: Knipe DM and Howley PM (eds) Philadelphia: Lippincott Williams and Wilkins pp. 2197–2229

    Google Scholar 

  • Huibregtse JM, Scheffner M, Howley PM . 1991 EMBO J. 10: 4129–4135

  • Huibregtse JM, Scheffner M, Beaudenon S, Howley PM . 1995 Proc. Natl. Acad. Sci. USA 92: 2563–2567

  • Hurlin PJ, Kaur P, Smith PP, Perez-Reyes N, Blanton RA, McDougall JK . 1991 Proc. Natl. Acad. Sci. USA 88: 570–574

  • Jones DL, Alani RM, Munger K . 1997 Genes Dev. 11: 2101–2111

  • Jones HW, Katayama KP, Stafl A, Davis HJ . 1967 Obst. Gynecol. 30: 790–805

  • Kashyap V, Das BC . 1998 Cancer Lett. 123: 47–52

  • Katich SC, Zerfass-Thome K, Hoffmann I . 2001 Oncogene 20: 543–550

  • Kessis TD, Connolly DC, Hedrick L, Cho KR . 1996 Oncogene 13: 427–431

  • Klingelhutz AJ, Foster SA, McDougall JK . 1996 Nature 380: 79–82

  • Koi M, Morita H, Yamada H, Satoh H, Barrett JC, Oshimura M . 1989 Mol. Carcinog. 2: 12–21

  • Lacey KR, Jackson PK, Stearns T . 1999 Proc. Natl. Acad. Sci. USA 96: 2817–2822

  • Larson AA, Liao SY, Stanbridge EJ, Cavenee WK, Hampton GM . 1997 Cancer Res. 57: 4171–4176

  • Lengauer C, Kinzler KW, Vogelstein B . 1998 Nature 396: 643–649

  • Lingle WL, Lutz WH, Ingle JN, Maihle NJ, Salisbury JL . 1998 Proc. Natl. Acad. Sci. USA 95: 2950–2955

  • Lowy DR, Howley PM . 2001 Field's Virology Vol. 2: Knipe DM and Howley PM (eds) Philadelphia: Lippincott Williams and Wilkens pp. 2231–2264

    Google Scholar 

  • Martin LG, Demers GW, Galloway DA . 1998 J. Virol. 72: 975–985

  • Matsumoto Y, Hayashi K, Nishida E . 1999 Curr. Biol. 9: 429–432

  • McCance DJ, Kopan R, Fuchs E, Laimins LA . 1988 Proc. Natl. Acad. Sci. USA 85: 7169–7173

  • Meraldi P, Honda R, Nigg EA . 2002 EMBO J. 21: 483–492

  • Meraldi P, Lukas J, Fry AM, Bartek J, Nigg EA . 1999 Nat. Cell Biol. 1: 88–93

  • Meyers C, Frattini MG, Hudson JB, Laimins LA . 1992 Science 257: 971–973

  • Munger K . 2002 Front. Biosci. 7: 641–649

  • Munger K, Basile JR, Duensing S, Eichten A, Gonzalez SL, Grace M, Zacny VL . 2001 Oncogene 20: 7888–7898

  • Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R . 1989 J. Virol. 63: 4417–4421

  • Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS . 2001 Nat. Cell Biol. 3: 785–792

  • Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K . 2000 Cell 103: 127–140

  • Pihan GA, Doxsey SJ . 1999 Sem. Cancer Biol. 9: 289–302

  • Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ . 1998 Cancer Res. 58: 3974–3985

  • Poignee M, Backsch C, Beer K, Jansen L, Wagenbach N, Stanbridge EJ, Kirchmayr R, Schneider A, Durst M . 2001 Cancer Res. 61: 7118–7121

  • Reid R, Crum CP, Herschman BR, Fu YS, Braun L, Shah KV, Agronow SJ, Stanhope CR . 1984 Cancer 53: 943–953

  • Rihet S, Lorenzato M, Clavel C . 1996 J. Clin. Pathol. 49: 892–896

  • Scheffner M, Huibregtse JM, Vierstra RD, Howley PM . 1993 Cell 75: 495–505

  • Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM . 1990 Cell 63: 1129–1136

  • Schulze A, Mannhardt B, Zerfass-Thome K, Zwerschke W, Jansen-Durr P . 1998 J. Virol. 72: 2323–2334

  • Skyldberg B, Fujioka K, Hellstrom AC, Sylven L, Moberger B, Auer G . 2001 Mod. Pathol. 14: 279–284

  • Solinas-Toldo S, Dürst M, Lichter P . 1997 Proc. Natl. Acad. Sci. USA 94: 3854–3859

  • Southern SA, Evans MF, Herrington CS . 1997 Cancer Res. 57: 4210–4213

  • Southern SA, Noya F, Meyers C, Broker TR, Chow LT, Herrington CS . 2001 Cancer Res. 61: 4858–4863

  • Steinbeck RG . 1997 Acta Oncol. 36: 3–12

  • Uejima H, Mitsuya K, Kugoh H, Horikawa I, Oshimura M . 1995 Genes Chrom. Cancer 14: 120–127

  • Vogelstein B, Lane D, Levine AJ . 2000 Nature 408: 307–310

  • Werness BA, Levine AJ, Howley PM . 1990 Science 248: 76–79

  • White AE, Livanos EM, Tlsty TD . 1994 Genes Dev. 8: 666–677

  • World Health Organisation. 1995 IARC Monogr. Eval. Carcinog. Risks Hum. 64: 35–378

  • Zerfass K, Schulze A, Spitkovsky D, Friedman V, Henglein B, Jansen-Durr P . 1995 J. Virol. 69: 6389–6399

  • Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-Durr P . 1996 Oncogene 13: 2323–2330

  • zur Hausen H . 1991 Science 254: 1167–1173

  • zur Hausen H . 1996 Biochim. Biophys. Acta 1288: F55–F78

Download references

Acknowledgements

We are grateful to Anette Duensing for critical reading of the manuscript, M Ericsson for performing electron microscopy and M Bornens for sharing reagents. Work in the authors' laboratory is supported by Public Health Service Grants R01 CA81135, R01 CA66980, and P01 DE00275 (K Münger) and a fellowship from the Deutsche Forschungsgemeinschaft (S Duensing).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Stefan Duensing or Karl Münger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duensing, S., Münger, K. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene 21, 6241–6248 (2002). https://doi.org/10.1038/sj.onc.1205709

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205709

Keywords

This article is cited by

Search

Quick links